161 filings
6-K
GNFT
Genfit
15 Apr 24
Current report (foreign)
4:10pm
6-K
GNFT
Genfit
5 Apr 24
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
2:03pm
20-F
2023 FY
GNFT
Genfit
Annual report (foreign)
5 Apr 24
11:44am
6-K
GNFT
Genfit
4 Apr 24
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
4:45pm
6-K
GNFT
Genfit
29 Feb 24
Current report (foreign)
4:10pm
6-K
f3s0t9
17 Jan 24
GENFIT Announces 2024 Financial Calendar
6:00am
6-K
l8it 1chnqqz52u2u4
11 Jan 24
Current report (foreign)
4:10pm
6-K
btyslolft ouhyk9
8 Dec 23
Current report (foreign)
8:00am
6-K
rqkzt
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
6-K
9rvejs
6 Dec 23
Current report (foreign)
11:30am
6-K
pkvljeydouut pdl5
16 Nov 23
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
4:10pm
6-K
n5pjuhyn tb
13 Nov 23
Current report (foreign)
4:30pm
6-K
o7wl sikkc9
9 Nov 23
GENFIT Reports Third Quarter 2023 Financial Information
4:10pm
6-K
1vltg wn1
6 Nov 23
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
7:00am
6-K
rj73i7 am6l6y8
26 Sep 23
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
4:10pm
6-K
dy7sg690fji12pmdcy
20 Sep 23
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
4:51pm
6-K
tf0w yvcpub8z8m0yzgz
20 Sep 23
Current report (foreign)
4:44pm
6-K
6st8h
5 Sep 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
lmcxa5
10 Aug 23
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications
4:10pm
6-K
99jqal6n4dt
12 Jul 23
Current report (foreign)
12:00am